Hikal Limited — Important, 30-07-2025: Updates

Hikal's Jigani plant has secured Good Manufacturing Practices (GMP) certification from Japan's Pharmaceutical and Medical Device Agency (PMDA) for its Active Pharmaceutical Ingredient (API) production. This confirms the facility's compliance with stringent Japanese quality standards, a significant positive for its API business. This validation enhances Hikal's credibility and strengthens its position for supplying APIs to the Japanese market, signaling robust operational quality.